DelveInsight’s “Astigmatism Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Astigmatism, historical and forecasted epidemiology as well as the Astigmatism market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Astigmatism market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Astigmatism Market Forecast

Some of the key facts of the Astigmatism Market Report:

• The Astigmatism market size is anticipated to grow with a significant CAGR during the study period (2019-2032).

• In January 2025, Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global leader in eye health, has announced the commercial launch of its enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union, following CE Mark approval received late last year. The enVista Aspire IOLs feature innovative Intermediate Optimized optics, offering an extended depth of focus, combined with the trusted enVista® platform to meet the visual demands of the modern, digital lifestyle. For patients with astigmatism, the enVista Aspire Toric IOLs present a reliable solution during cataract surgery, with a +0.90 cylinder design capable of correcting less than one diopter of corneal astigmatism.

• Key Astigmatism Companies: Technolas Perfect Vision GmbH, Abbott Medical Optics, Bausch & Lomb Incorporated, Durrie Vision, Novartis AG, SEA VISION S.r.l, Johnson & Johnson Services, Inc, CooperVision, Carl Zeiss Meditec AG, Seed Co., Ltd, Essilor Group, and others

• The Astigmatism market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Astigmatism pipeline products will significantly revolutionize the Astigmatism market dynamics.

Astigmatism Overview

Astigmatism is a common vision condition caused by an irregularly shaped cornea or lens, leading to blurred or distorted vision. Instead of being perfectly round, the cornea or lens is shaped more like a football, which prevents light from focusing properly on the retina. This can cause difficulty seeing clearly at any distance. Astigmatism often occurs alongside nearsightedness or farsightedness and can be corrected with glasses, contact lenses, or refractive surgery.

Get a Free sample for the Astigmatism Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/astigmatism-market

Signs and Symptoms of Astigmatism and Associated Risk Factors

Astigmatism manifests with symptoms that can vary in severity. Common signs include blurred or distorted vision, eyestrain, headaches, and difficulties seeing clearly at night. Individuals with astigmatism may also experience squinting or frequent changes in glasses or contact lens prescriptions. While the exact cause of astigmatism is not always clear, certain risk factors contribute to its development. These include genetics, eye injuries, and conditions such as keratoconus. Understanding these risk factors aids in identifying individuals who may be more susceptible to astigmatism and implementing preventive measures.

Diagnosing Astigmatism: A Comprehensive Eye Examination

Diagnosing astigmatism involves a comprehensive eye examination conducted by an optometrist or ophthalmologist. The examination includes a review of medical history, visual acuity tests, and refraction assessment to determine the extent and type of refractive error. Specialized instruments like keratometers and corneal topographers may be used to measure the curvature of the cornea and identify irregularities contributing to astigmatism. Early and accurate diagnosis is crucial for prescribing corrective lenses or exploring other treatment options.

Astigmatism Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Astigmatism Epidemiology Segmentation:

The Astigmatism market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Astigmatism

• Prevalent Cases of Astigmatism by severity

• Gender-specific Prevalence of Astigmatism

• Diagnosed Cases of Episodic and Chronic Astigmatism

Download the report to understand which factors are driving Astigmatism epidemiology trends @ Astigmatism Epidemiology Forecast

Evolving Treatment Outlook for Astigmatism

The treatment of astigmatism primarily focuses on correcting the refractive error to improve visual acuity. The main treatment options include eyeglasses and contact lenses, designed to compensate for the irregular corneal shape and provide clear vision. Refractive surgery, such as LASIK or PRK, is another option for those seeking a more permanent solution. These surgical procedures reshape the cornea to enhance its focusing abilities. While not all individuals with astigmatism are candidates for surgery, technological advancements continue to refine these procedures, expanding treatment options for a broader range of patients.

Market Outlook and Growth Factors in Astigmatism Research

The market for astigmatism correction is influenced by technological advancements in eyewear, contact lenses, and refractive surgery. The increasing prevalence of astigmatism worldwide contributes to the market’s growth. Innovative lens designs, materials, and surgical techniques play a role in meeting the diverse needs of individuals with astigmatism. Moreover, a growing emphasis on vision correction and eye care awareness contributes to the demand for effective and accessible treatments. Collaborations between eyewear manufacturers, healthcare providers, and research institutions drive progress in astigmatism management, enhancing the market’s outlook for improved visual outcomes and enhanced quality of life for affected individuals.

Astigmatism Treatment Devices and Key Companies

• Laser-assisted Astigmatic keratotomy: Technolas Perfect Vision GmbH

• iFS Femtosecond Laser System: Abbott Medical Optics

• Akreos Toric IOL: Bausch & Lomb Incorporated

• Excimer Laser: Durrie Vision

• Toric IOL (SN60T3): Alcon Research

Discover more about therapies set to grab major Astigmatism market share @ Astigmatism Medications

Astigmatism Market Drivers

• Rising prevalence of refractive errors

• Technological advancements

• Growing awareness and screening programs

• Aging population

• Expanding health insurance coverage

Astigmatism Market Barriers

• High cost of advanced treatment options

• Limited awareness in rural areas

• Shortage of ophthalmologists in certain regions

• Side effects and risks associated with surgical correction

• Economic disparities

Scope of the Astigmatism Market Report

• Study Period: 2019–2032

• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

• Key Astigmatism Companies: Technolas Perfect Vision GmbH, Abbott Medical Optics, Bausch & Lomb Incorporated, Durrie Vision, Novartis AG, SEA VISION S.r.l, Johnson & Johnson Services, Inc, CooperVision, Carl Zeiss Meditec AG, Seed Co., Ltd, Essilor Group, and others

• Astigmatism Therapeutic Assessment: Astigmatism current marketed and Astigmatism emerging therapies

• Astigmatism Market Dynamics: Astigmatism market drivers and Astigmatism market barriers

• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

• Astigmatism Unmet Needs, KOL’s views, Analyst’s views, Astigmatism Market Access and Reimbursement

To know more about Astigmatism companies working in the treatment market, visit @ Astigmatism Clinical Trials and Therapeutic Assessment

Table of Contents

1. Astigmatism Market Report Introduction

2. Executive Summary for Astigmatism

3. SWOT analysis of Astigmatism

4. Astigmatism Patient Share (%) Overview at a Glance

5. Astigmatism Market Overview at a Glance

6. Astigmatism Disease Background and Overview

7. Astigmatism Epidemiology and Patient Population

8. Country-Specific Patient Population of Astigmatism

9. Astigmatism Current Treatment and Medical Practices

10. Astigmatism Unmet Needs

11. Astigmatism Emerging Therapies

12. Astigmatism Market Outlook

13. Country-Wise Astigmatism Market Analysis (2019–2032)

14. Astigmatism Market Access and Reimbursement of Therapies

15. Astigmatism Market Drivers

16. Astigmatism Market Barriers

17. Astigmatism Appendix

18. Astigmatism Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/